First experience of topical SDZ ASM 981 in children with atopic dermatitis.
about
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patientsNonsteroidal Topical Immunomodulators in Allergology and DermatologyPimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infantsChildhood atopic eczemaPimecrolimus does not affect Langerhans cells in murine epidermis.Therapeutic options for chronic hand dermatitis.What's new in atopic dermatitis?What is new in therapy?New treatments for atopic dermatitis.Treatment principles of atopic dermatitis.Pimecrolimus: a review.The role of topical calcineurin inhibitors in atopic dermatitis.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Problem-based learning: a review of current issues relevant to physiotherapy education.Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance.Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.Pimecrolimus for psoriasis.Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.Treatment of atopic dermatitis with pimecrolimus - impact on quality of life.Skin absorption through atopic dermatitis skin: a systematic review.Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study.Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus.Ascomycin: an advance in the management of atopic dermatitis.[Long term management of childhood atopic dermatitis with calcineurin inhibitors].Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.Low systemic absorption and good tolerability of pimecrolimus, administered as 1% cream (Elidel) in infants with atopic dermatitis--a multicenter, 3-week, open-label study.Atopic dermatitis: a review of topical nonsteroid therapy.Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report
P2860
Q24675365-6AD61CEB-80E5-4283-B69F-DFC678828971Q26752832-6CD79C51-8766-45D5-AC33-88F2D17CEF6BQ28086973-3377FB41-0CAE-4784-A048-C34511D63102Q31071262-E07E65CE-59D6-4ECA-B440-95904D5649ECQ34276712-DA05ACB7-1483-4F95-B141-01B1E1AF6648Q34325706-57B20BB3-FB31-4EB6-8D25-7964CD90B25BQ34352747-31C69CA2-8D1D-4C3B-94B7-8391811B440EQ34459067-588F7771-BC50-4931-A8CD-D53EA9022B21Q34592295-B3F55790-ADC9-4B79-8615-4B826688C4A9Q34600248-98E38A6E-A716-48ED-A173-A16FAE7773FBQ35206755-B50B8655-0641-465F-926F-5BBCF9A263BFQ35952647-7CE0573A-4B08-4B5B-A5A6-DA8B2DA3AEE5Q36222741-9B489046-8EDA-4D88-ABA0-6FE405B1D78BQ36356956-A2A6E7F7-04FE-4680-A2A0-463D587A3F98Q36681795-45160A9D-994F-4489-92E7-92FE5888C7E6Q36861654-53446510-5B2C-42D2-9A27-36C48E7EDBB1Q36892767-2BA92C55-1D86-4588-9847-6D6B9FAAA6A2Q37049981-E1247C3E-2B75-442F-95A6-29CF8E8AD65FQ37049990-597E0A66-DD66-478A-8439-26B8BC920035Q38084638-DDC4E901-9CCD-4FB0-B8C0-0391AEB016A3Q38086585-DA0DFA17-38C4-42BA-A677-262E51DDD43BQ38123240-59C0230F-8CE0-4612-BA83-F6403DFB422BQ38536150-F23E507B-B702-42A4-B4C9-4F33D1CC301DQ38957449-453D48C4-5808-41F1-954F-C31906FCB92EQ40619262-B17AE14D-D799-4B28-BC78-543B4F46D7F5Q41771409-7FEEC9D1-FADA-4A09-98C9-A2F0C23BFCE7Q43572222-849D2E96-6ECF-4697-9936-A86FDC5538C9Q44420855-77C05CA7-3D08-4F4F-AE2E-5315E6FC4365Q46701419-303714D0-1E21-4ABE-8366-CF89C4AEB034Q46725937-D2904BCC-D463-4835-B072-06B13F187F9BQ52597622-A3E6EDE3-B484-4068-B242-A908FA59637EQ57072093-CC743056-2668-420F-BE20-E7F400C78509
P2860
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@en
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@nl
type
label
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@en
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@nl
prefLabel
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@en
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@nl
P2093
P1476
First experience of topical SDZ ASM 981 in children with atopic dermatitis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2133.2001.04133.X
P407
P577
2001-04-01T00:00:00Z